Leucadia Therapeutics
business-people-talking-in-corridor-PSVCLEM.jpg

About Us

Who We Are, What We Do 

Led by Founder and CEO Doug Ethell, Leucadia Therapeutics has looked at Alzheimer's disease with new eyes. We have assembled an amazing team of dedicated professionals who are focused on CURING Alzheimer’s disease. 

This mission-oriented team discovered a major trigger for Alzheimer’s disease pathology and has developed a patented strategy to correct that condition.

 

Follow Up

Leucadia Therapeutics has a novel approach to treating Alzheimer's disease.

Get in touch with us ▸


OUR TEAM

Doug.png

Doug Ethell, PhD

FOUNDER & CEO

Previously Professor of Neuroscience Chair, Graduate College of Biomedical Science Head, Molecular Neurobiology Group, 15 years of Alzheimer’s Disease research, Awarded >$3M in research funding. Authored >85 papers & abstracts

Dave.png

David Gobel 

SENIOR ADVISOR

Serial Entrepreneur, Incubator Specialist, CEO of the Methuselah Foundation, Former Chief Venture Strategist at TSA                     

 

 
DanMiulliBW.png

Dan Miulli, D.O. MS, FACOS

SCIENTIFIC ADVISORY BOARD

Neurosurgeon - Arrowhead Regional Medical Center, Director - Neurosurgery Residence Program, Colton, CA

                                     

Javed2.png

Javed Siddiqui, MD, PhD

SCIENTIFIC ADVISORY BOARD

Neurosurgeon - Arrowhead Regional Medical Center, Director - Desert Regional Medical Center, Neurological Surgery Residency - Desert Regional Medical Center, Palm Springs, CA     

Tea.png

Tea Jashashvili, MD, PhD

SCIENTIFIC ADVISORY BOARD

 Assistant Professor of Research Radiology - Molecular Imaging Center (MIC), Department of Radiology at the University of Southern California. 


 

Founding Investors